Kesbury
Sermorelin · Pricing

How much does sermorelin cost?

The published price, what it covers, why the lab panel is billed separately, and why a per-vial number found elsewhere is not the same purchase.

Medically reviewed by the Kesbury Health Clinical Team · Last updated 2026-09-02

Quick answer

Sermorelin therapy at Kesbury Health is $279 per month, and the Sermorelin Baseline Panel that comes first is $179 one time. The Longevity Stack, which combines NAD+ therapy and sermorelin, is $499 per month, which is below the sum of the two bought separately. These are flat cash prices. There is no membership fee on top, no insurance billing, and no clinic facility charge, and you can cancel. What that price covers is not just a vial: it covers the physician evaluation, the prescription, compounding and dispensing by a licensed U.S. pharmacy, shipping to your door, and ongoing physician oversight with a 90-day re-evaluation. Prices found elsewhere for a bare vial are not comparable, because they price a different thing.

What the monthly price includes

  • Physician evaluation. A licensed physician reviews your intake and decides whether sermorelin is a reasonable fit, or whether it is not.
  • The medication. Compounded by a licensed U.S. 503A pharmacy against a prescription written for you, and shipped to your door.
  • Dose setting and adjustment. Individualized rather than taken from a chart, and revisited over time.
  • Ongoing oversight. Including a 90-day re-evaluation built into the sermorelin program.
  • A care team you can reach between visits.

Why the lab panel is priced separately

The $179 Sermorelin Baseline Panel is a prerequisite for sermorelin therapy here, and it is listed as its own line rather than folded into the subscription. That is deliberate. A panel folded into a monthly price starts to look like an administrative formality; a panel with its own price is visibly a step that can end in "no". Its results can mean therapy is not prescribed, and you should be able to see that decision point in the pricing.

Baseline IGF-1 also has a technical job: it is the reference point that later results are compared against when the dose is adjusted. Comparing an outside result from a different laboratory against a different reference range is a well-recognised way to reach a wrong conclusion, which a 2011 consensus statement in Clinical Chemistry addressed directly [2].

Why a vial price is not a program price

Search for sermorelin and you will find numbers far below $279. Most of them are one of three things: a per-vial compounding-pharmacy price that assumes you already have a prescription and a prescriber, a research-use-only listing that is not a medication dispensed for human use, or an introductory rate that resets. None of those includes the evaluation, the labs, the dose decisions, or the follow-up.

This is a general pattern in direct-to-consumer telehealth rather than a claim about any particular seller. In a 2016 JAMA Dermatology study, researchers submitted 62 clinical encounters to 16 direct-to-consumer telemedicine websites between 4 February and 11 March 2016, and reported that prescription medications were ordered in 31 of 48 diagnosed cases, or 65%, while disclosure of clinician identity, licensure and cost was often poor [3]. Price transparency and clinical transparency tend to travel together.

How to compare two sermorelin offers honestly

  1. Is a licensed physician evaluating you, and can you tell before you pay?
  2. Are labs part of the process, and does the process allow the answer to be no?
  3. Who compounds and dispenses, and is it a licensed U.S. pharmacy?
  4. Is the full price published, including labs and shipping, before checkout?
  5. What happens at month four, when a re-evaluation should happen?
  6. How do you cancel, and is that written down?

Endocrine Society guidance for growth hormone therapy makes the underlying point about monitoring: measurement and follow-up are part of the therapy, not an optional extra [1]. A price that omits them is cheaper because it is buying less.

Kesbury Health pricing at a glance

  • Sermorelin Therapy: $279 per month.
  • Sermorelin Baseline Panel: $179 one time, prerequisite for sermorelin.
  • NAD+ Therapy: $299 per month.
  • Longevity Stack (NAD+ and sermorelin): $499 per month.

No insurance billing, no membership fee, and cancellation is available. Care is delivered by telehealth in the ten states where your Kesbury Health physician is licensed.

How physician-directed sermorelin works at Kesbury Health

  1. Complete a short online assessment about your goals, symptoms and health history. It takes about 60 seconds to begin.
  2. A licensed Kesbury Health physician reviews what you submitted and decides whether therapy is a reasonable fit for you, or whether something else should be looked at first.
  3. Baseline labs where they apply. The $179 Sermorelin Baseline Panel is a prerequisite for sermorelin therapy, and the results can end the conversation rather than continue it.
  4. If therapy is appropriate, the medication is compounded by a licensed U.S. pharmacy and shipped to your door, with dosing set to you rather than to a chart.
  5. Ongoing physician oversight adjusts the protocol over time, with a 90-day re-evaluation built into the sermorelin program.

Care is delivered by telehealth to residents of the ten states where your Kesbury Health physician is licensed: Alabama, District of Columbia, Delaware, Florida, Maryland, Michigan, New Jersey, Ohio, Pennsylvania and Texas. Eligibility is confirmed during the assessment.

Frequently asked questions

How much does sermorelin cost at Kesbury Health?

Sermorelin therapy is $279 per month. The Sermorelin Baseline Panel, which is a prerequisite for therapy, is $179 one time. The Longevity Stack, which combines NAD+ and sermorelin, is $499 per month. Those are flat cash prices with no membership fee layered on top, and you can cancel.

Why is there a separate charge for labs?

Because the panel is a real clinical step with a real cost, and burying it inside a monthly price would hide the fact that it can end the conversation. The $179 panel is a prerequisite for sermorelin therapy and its results can mean therapy is not prescribed.

Does insurance cover sermorelin?

No. Compounded sermorelin prescribed for healthy-aging goals is a cash-pay therapy, and Kesbury Health does not bill insurance. That is why the price is published rather than quoted after a consultation.

Why do per-vial prices found elsewhere look cheaper?

Because a vial price is not a program price. A per-vial or research-use-only listing does not include the physician evaluation, the baseline panel, the follow-up, or a licensed pharmacy dispensing against a prescription written for you. A 2016 JAMA Dermatology study of direct-to-consumer telemedicine sites found that pricing and clinician disclosure were frequently unclear to the patient [3], which is the pattern to watch for.

Can I cancel?

Yes. Sermorelin therapy is billed monthly and you can cancel. The published refund policy on this site sets out how billing and cancellation work.

See the full price before you commit

Take the free 60-second Kesbury Health assessment. Pricing is published up front, the baseline panel comes before any prescription, and the answer can be that sermorelin is not the right fit.

Start your free 60-second assessment →

Kesbury Health is a LegitScript-certified (#51875982) telehealth longevity practice licensed in ten states. Sermorelin and NAD+ are compounded medications prescribed by a licensed physician after review. Compounded medications are not FDA-approved. This page is educational and is not individualized medical advice. Statements on this page have not been evaluated by the FDA. Individual results vary.

References (primary sources)

Every reference below was checked against its PubMed record on 2026-09-02. Links open the abstract.

  1. Molitch ME, Clemmons DR, Malozowski S, Merriam GR, Vance ML. Evaluation and treatment of adult growth hormone deficiency: an Endocrine Society clinical practice guideline. Journal of Clinical Endocrinology and Metabolism. 2011;96(6):1587-1609. doi:10.1210/jc.2011-0179. PMID 21602453.
  2. Clemmons DR. Consensus statement on the standardization and evaluation of growth hormone and insulin-like growth factor assays. Clinical Chemistry. 2011;57(4):555-559. doi:10.1373/clinchem.2010.150631. PMID 21285256.
  3. Resneck JS Jr, Abrouk M, Steuer M, Tam A, et al. Choice, transparency, coordination, and quality among direct-to-consumer telemedicine websites and apps treating skin disease. JAMA Dermatology. 2016;152(7):768-775. doi:10.1001/jamadermatol.2016.1774. PMID 27180232.

Keep reading